RE:RE:RE:volume picking upI hear you Macpoor as I have been banged up and beaten down many times over investing.
You are likely better at technical analysis then I am because I am terrible at it.
Thankfully things have worked out well for me even though I can't trade for the life of me or understand technical charts.
In my opinion DPM worked out well companred to things like Parc Vancouver, the Dundee Zoo (fish, cattle, chickens, etc : ), Oil and Gas, etc.
If I am managing a hedgefund and want 2% of my fund to be intermediate miner exposure I am going to look for the easiest way to do this. Sooner or later Dundee will check most of the boxes and will get fund flows.
______________________________________
Lilly's Donanemab works very well but there are safety concerns (https://www.science.org/content/article/it-s-not-miracle-drug-eli-lilly-antibody-slows-alzheimer-s-disease-safety-issues-linger)
Biogens Lecanemab also works very well but also has safety concerns.
Does that leave room for TauRx?
I value TauRx like an option (Big Upside if approved)